Insider Transactions in Q3 2023 at 23and Me Holding Co. (ME)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 21
2023
|
Kathy L Hibbs Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
38,548
-2.91%
|
$38,548
$1.0 P/Share
|
|
Sep 21
2023
|
Kathy L Hibbs Chief Administrative Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
38,548
+2.83%
|
$0
$0.42 P/Share
|
|
Sep 15
2023
|
Kathy L Hibbs Chief Administrative Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,025,992
+44.4%
|
-
|
|
Sep 15
2023
|
William G Richards Head of Therapeutics Discovery |
BUY
Grant, award, or other acquisition
|
Direct |
459,691
+26.48%
|
-
|
|
Sep 15
2023
|
Joseph Anthony Selsavage Chief Financial & Actng Ofcr |
BUY
Grant, award, or other acquisition
|
Direct |
1,025,992
+43.69%
|
-
|
|
Sep 07
2023
|
Kathy L Hibbs Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
40,894
-13.64%
|
$40,894
$1.06 P/Share
|
|
Sep 07
2023
|
Kathy L Hibbs Chief Administrative Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
40,894
+12.0%
|
$0
$0.42 P/Share
|
|
Sep 06
2023
|
Patrick S Chung Director |
BUY
Grant, award, or other acquisition
|
Direct |
188,387
+25.8%
|
$0
$0.55 P/Share
|
|
Sep 06
2023
|
Neal Mohan Director |
BUY
Grant, award, or other acquisition
|
Direct |
154,997
+38.67%
|
-
|
|
Sep 06
2023
|
Rice Valerie Md Montgomery Director |
BUY
Grant, award, or other acquisition
|
Direct |
190,495
+23.4%
|
$0
$0.55 P/Share
|
|
Sep 06
2023
|
Richard H Scheller Director |
BUY
Grant, award, or other acquisition
|
Direct |
165,088
+41.01%
|
-
|
|
Sep 06
2023
|
Sandra R Md Hernandez Director |
BUY
Grant, award, or other acquisition
|
Direct |
194,363
+22.85%
|
$0
$0.55 P/Share
|
|
Sep 06
2023
|
Peter J. Taylor Director |
BUY
Grant, award, or other acquisition
|
Direct |
137,566
+34.15%
|
-
|
|
Sep 06
2023
|
Roelof Botha Director |
BUY
Grant, award, or other acquisition
|
Direct |
193,379
+36.08%
|
$0
$0.55 P/Share
|
|
Sep 05
2023
|
William G Richards Head of Therapeutics Discovery |
SELL
Open market or private sale
|
Direct |
2,538
-1.19%
|
$2,538
$1.08 P/Share
|
|
Aug 24
2023
|
Kathy L Hibbs Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
40,894
-13.94%
|
$40,894
$1.05 P/Share
|
|
Aug 24
2023
|
Kathy L Hibbs Chief Administrative Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
40,894
+12.23%
|
$0
$0.42 P/Share
|
|
Aug 20
2023
|
Kathy L Hibbs Chief Administrative Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,628
-1.8%
|
$4,628
$1.14 P/Share
|
|
Aug 20
2023
|
William G Richards Head of Therapeutics Discovery |
SELL
Payment of exercise price or tax liability
|
Direct |
8,185
-3.73%
|
$8,185
$1.14 P/Share
|
|
Aug 20
2023
|
Joseph Anthony Selsavage Chief Financial & Actng Ofcr |
SELL
Payment of exercise price or tax liability
|
Direct |
6,209
-2.12%
|
$6,209
$1.14 P/Share
|
|
Aug 15
2023
|
Kathy L Hibbs Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
40,894
-13.72%
|
$40,894
$1.32 P/Share
|
|
Aug 15
2023
|
Kathy L Hibbs Chief Administrative Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
40,894
+12.07%
|
$0
$0.42 P/Share
|
|
Jul 27
2023
|
Kathy L Hibbs Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
40,894
-13.72%
|
$40,894
$1.89 P/Share
|
|
Jul 27
2023
|
Kathy L Hibbs Chief Administrative Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
40,894
+12.07%
|
$0
$0.42 P/Share
|
|
Jul 13
2023
|
Kathy L Hibbs Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
40,894
-13.72%
|
$40,894
$1.82 P/Share
|
|
Jul 13
2023
|
Kathy L Hibbs Chief Administrative Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
40,894
+12.07%
|
$0
$0.42 P/Share
|